Lifecore Biomedical Inc (STU:LDE)
€ 6.7 0.1 (1.52%) Market Cap: 248.22 Mil Enterprise Value: 374.15 Mil PE Ratio: 140.60 PB Ratio: 0 GF Score: 69/100

Q2 2022 Landec Corp Earnings Call Transcript

Jan 05, 2022 / 10:00PM GMT
Release Date Price: €9.3 (-3.63%)
Operator

Good afternoon, and thank you for joining Landec's Fiscal 2022 Second Quarter Earnings Call. (Operator Instructions).

Now I would like to turn the call over to Jeff Sonnek, Investor Relations at ICR.

Jeff Sonnek
ICR, LLC - SVP

Good afternoon, and thank you for joining us today to discuss Landec Corporation's Second Quarter Fiscal 2022 Earnings Results.

On the call today from the company are Dr. Albert Bolles, President and Chief Executive Officer; John Morberg, Chief Financial Officer; and Jim Hall, President of Lifecore.

By now, everyone should have access to the press release, which went out today just after 1:00 p.m. Pacific or 4:00 p.m. Eastern. If you've not received the release, it's available on the Investor Relations portion of Landec's website at ir.landec.com.

Before we begin today, we'd like to remind everyone of the safe harbor statement. Certain statements made in the course of this conference call contain forward-looking statements. It's important to note that the company's actual results could differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot